Oxford Immunotec Limited Announces Appointment of Richard Alteri as Chief Financial Officer
OXFORD, England & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Oxford Immunotec Ltd. an immunology focused diagnostic company, announces the appointment of Richard (Rick) Alteri as Chief Financial Officer (CFO).
Prior to joining Oxford Immunotec, Mr. Altieri was Vice President and Chief Financial Officer of Salient Surgical Technologies, Inc. a medical technology company that develops and markets surgical advanced energy products. At Salient, he led all financing activities, prepared to take the company public and played a key role in the ultimate sale of the company to Medtronic.
Prior to joining Oxford Immunotec, Mr. Altieri was Vice President and Chief Financial Officer of Salient Surgical Technologies, Inc. a medical technology company that develops and markets surgical advanced energy products. At Salient, he led all financing activities, prepared to take the company public and played a key role in the ultimate sale of the company to Medtronic.